HeartBeam Price to Book Ratio 2020-2025 | BEAT
Historical price to book ratio values for HeartBeam (BEAT) over the last 10 years. The current price to book ratio for HeartBeam as of May 30, 2025 is 7.61.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
HeartBeam Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2025-05-30 | 1.70 | 7.62 | |
2025-03-31 | 2.01 | $0.22 | 9.01 |
2024-12-31 | 2.30 | $0.06 | 37.52 |
2024-09-30 | 2.32 | $0.18 | 12.85 |
2024-06-30 | 2.57 | $0.33 | 7.84 |
2024-03-31 | 2.18 | $0.48 | 4.58 |
2023-12-31 | 2.35 | $0.61 | 3.88 |
2023-09-30 | 2.15 | $0.71 | 3.04 |
2023-06-30 | 2.41 | $0.81 | 2.97 |
2023-03-31 | 2.27 | $-0.10 | -21.74 |
2022-12-31 | 4.88 | $0.30 | 16.46 |
2022-09-30 | 3.90 | $0.72 | 5.44 |
2022-06-30 | 1.29 | $1.12 | 1.15 |
2022-03-31 | 1.84 | $1.54 | 1.20 |
2021-12-31 | 3.08 | $1.72 | 1.79 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.057B | $0.000B |
HeartBeam Inc. is a development stage digital healthcare company with proprietary ECG telemedicine technology. HeartBeam Inc. is based in SANTA CLARA, Calif. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $45.506B | 58.15 |
Hims & Hers Health (HIMS) | United States | $12.660B | 131.54 |
Tempus AI (TEM) | United States | $9.553B | 0.00 |
IRhythm Technologies (IRTC) | United States | $4.486B | 0.00 |
Inspire Medical Systems (INSP) | United States | $4.076B | 63.69 |
Hinge Health (HNGE) | United States | $3.030B | 0.00 |
Privia Health (PRVA) | United States | $2.775B | 189.67 |
Enovis (ENOV) | United States | $1.788B | 9.97 |
Clover Health Investments (CLOV) | United States | $1.598B | 0.00 |
Schrodinger (SDGR) | United States | $1.586B | 0.00 |
Phreesia (PHR) | United States | $1.457B | 0.00 |
Omnicell (OMCL) | United States | $1.423B | 25.10 |
Azenta (AZTA) | United States | $1.223B | 56.85 |
10x Genomics (TXG) | United States | $1.173B | 0.00 |
Claritev (CTEV) | United States | $0.632B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.631B | 0.00 |
Butterfly Network (BFLY) | United States | $0.593B | 0.00 |
Talkspace (TALK) | United States | $0.534B | 159.50 |
Veradigm (MDRX) | United States | $0.466B | 0.00 |
Standard BioTools (LAB) | United States | $0.384B | 0.00 |
TruBridge (TBRG) | United States | $0.360B | 797.67 |
Outset Medical (OM) | United States | $0.311B | 0.00 |
Health Catalyst (HCAT) | United States | $0.264B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.261B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.200B | 0.00 |
Pulmonx (LUNG) | United States | $0.137B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.136B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.125B | 0.00 |
American Well (AMWL) | United States | $0.105B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.100B | 0.00 |
CareCloud (CCLD) | United States | $0.085B | 3.26 |
111 (YI) | China | $0.071B | 0.00 |
P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
Zhongchao (ZCMD) | China | $0.029B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
Precipio (PRPO) | United States | $0.014B | 0.00 |
MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
Movano (MOVE) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |